Global Neuroscience Market size was valued at USD 49.5 Billion in 2024 and is expected to reach USD 67.6 Billion by 2033, at a CAGR of 5.9% during the forecast period 2024 – 2033.
Neuroscience Market: Overview
Neuroscience is the scientific investigation of the nervous system, which includes the cerebral cortex, spinal cord, and peripheral nerves. It includes a wide range of fields, from biochemical and cellular neuroscience, which studies the basic building blocks of the nervous system, to cognition and behavioral neuroscience, which investigates higher-level processes like memory, cognition, and consciousness.
Precision medicine and personalized therapies are becoming increasingly important, because of advances in genetics, biomarkers, and statistical analytics, which allow for specific approaches to neurological illnesses. Furthermore, there is a growing interest in brain health and cerebral enhancement, which has led to the creation of nootropics, neurostimulation devices, and digital treatments to improve cognitive performance and mental well-being.
Furthermore, neurotechnology, such as neuroimaging, neurological regulation, and brain-computer interactions, is transforming both research and therapeutic applications in neuroscience. In addition, collaborative initiatives and multidisciplinary methods are gaining popularity, with academia, business, and government agencies working together to expedite innovation and address difficult neurological concerns.
Emphasis on patient-centered care and advocacy will drive efforts to expand treatment access, decrease stigma, and enhance the quality of life for patients with neurological diseases.
By component, the instrument segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. Instruments fuel the medical neuroscience industry by facilitating research, evaluation, and treatment using instruments including imaging systems, electrophysiological equipment, and DNA analysis platforms, allowing for advances in recognizing and managing neurological problems.
By technology, the brain imaging segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. Brain imaging propels the neuroscience industry by allowing for the visualization and clarification of brain structure and function, which aids in the study, diagnosis, and creation of treatments for neurological diseases and injuries.
By end user, the diagnostic laboratories segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. Diagnostic laboratories boost the neuroscience industry by offering critical assessment and testing services for neurological illnesses, which help in early identification, precise diagnosis, and personalized therapy planning for patients.
North America dominates the neuroscience industry because of its excellent research facilities substantial investments in health care and biological sciences, huge patient population, favorable regulatory environment, and robust industry-academic relationships that stimulate innovation.
GE Healthcare manufactures and distributes diagnostic imaging medicines and radioactive substances for various types of imaging used in medical operations. It provides dyes for MR imaging processes, medical diagnostic equipment such as CT image machines, MRI, XRAY, ultrasound, cath labs, mammograms, and builds technology for medical imaging, tracking of patient’s systems, research into diseases, drug development, and biopharmaceutical production.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 49.5 Billion |
| Projected Market Size in 2033 | USD 67.6 Billion |
| Market Size in 2023 | USD 47.1 Billion |
| CAGR Growth Rate | 5.9% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Component, Technology, End User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
CMI has comprehensively analyzed the Global Neuroscience market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Global Neuroscience industry.
The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.
List of the prominent players in the Neuroscience Market:
- Eli Lilly and Company
- Biogen Inc.
- Novartis AG
- Pfizer Inc.
- Johnson & Johnson
- Merck & Co. Inc.
- AbbVie Inc.
- GlaxoSmithKline plc
- AstraZeneca PLC
- Sanofi S.A.
- Bristol Myers Squibb
- Hoffmann-La Roche Ltd
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- UCB S.A.
- Boehringer Ingelheim International GmbH
- Allergan plc
- Eisai Co. Ltd.
- Otsuka Holdings Co. Ltd.
- Lundbeck A/S
- Others
The Neuroscience Market is segmented as follows:
By Component
- Instruments
- Consumables
- Software & Services
By Technology
- Brain Imaging
- Neuro-Microscopy
- Stereotaxic Surgeries
- Neuro-Proteomic Analysis
- Neuro-Cellular Manipulation
- Others
By End User
- Hospitals
- Diagnostic laboratories
- Research and Academic Institute
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America